A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Researchers are looking for new ways to treat metastatic cervical cancer. Cervical cancer is cancer in the cervix, the lower part of the uterus (womb). Metastatic means the cancer has spread to other parts of the body. Researchers want to learn about giving the study medicine sacituzumab tirumotecan (also called sac-TMT or MK-2870) along with pembrolizumab and bevacizumab treatments. Sac-TMT is an antibody drug conjugate, which is a type of medicine that attaches to specific targets on cancer cells and delivers treatment to destroy those cells. The goals of this study are to learn: * About the safety of sac-TMT with pembrolizumab and bevacizumab, and if people tolerate them when given together, and * If people who receive sac-TMT and pembrolizumab, with or without bevacizumab, live longer overall or without their cancer getting worse as compared to those who receive standard treatment
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjentka ma potwierdzony laboratoryjnie rak szyjki macicy.
- •Rak szyjki macicy jest nieuleczalny standardowymi metodami (operacja, radioterapia) i rozprzestrzenił się.
- •Zakażenie wirusem HIV jest dobrze kontrolowane przez leki.
- •Wirusowe zapalenie wątroby typu B lub C jest dobrze kontrolowane przez leki.
✗ Disqualifies
- •Pacjentka miała ciężkie problemy z oczami, które mogłyby utrudnić leczenie.
- •Pacjentka ma aktywne choroby zapalne jelit wymagające leków osłabiających odporność.
- •Pacjentka ma poważne, niekontrolowane choroby serca lub naczyń mózgowych.
- •Pacjentka otrzymała inne, nieokreślone w tym badaniu leczenie raka.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 2, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (138)
Mount Sinai Comprehensive Cancer Center ( Site 6000)
Miami Beach, United States
Florida Cancer Specialists - East ( Site 7000)
West Palm Beach, United States
Winship Cancer Institute of Emory University ( Site 5005)
Atlanta, United States
Nancy N. & J.C. Lewis Cancer and Research Pavillion - Research Department ( Site 6005)
Savannah, United States
TRIALS 365 ( Site 6008)
Shreveport, United States
Minnesota Oncology Hematology, PA ( Site 8003)
Edina, United States
Women's Cancer Center of Nevada ( Site 6011)
Las Vegas, United States
Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 6009)
New York, United States
Oklahoma Cancer Specialists and Research Institute, LLC ( Site 6001)
Tulsa, United States
Oncology Associates of Oregon, P.C.(Willamette Valley Cancer Institute) (WVCI) ( Site 8007)
Eugene, United States
Women & Infants Hospital ( Site 6003)
Providence, United States
University of Tennessee Medical Center ( Site 6012)
Knoxville, United States
Texas Oncology - DFW ( Site 8005)
Fort Worth, United States
Texas Oncology-The Woodlands ( Site 8000)
The Woodlands, United States
Texas Oncology - Northeast Texas ( Site 8002)
Tyler, United States
University of Virginia Cancer Center ( Site 6014)
Charlottesville, United States
Centro de Oncología e Investigación de Buenos Aires ( Site 0107)
Berazategui, Argentina
Instituto de Investigaciones Clinicas Mar del Plata ( Site 0105)
Mar del Plata, Argentina
Fundación Respirar ( Site 0101)
Belgrano, Argentina
Instituto Misionero del Cancer ( Site 0112)
Posadas, Argentina
Instituto de Oncologia de Rosario ( Site 0104)
Rosario, Argentina
Hospital Provincial del Centenario ( Site 0106)
Rosario, Argentina
Fundación CORI para la Investigación y Prevención del Cáncer ( Site 0111)
La Rioja, Argentina
Medizinische Universitaet Wien ( Site 0302)
Vienna, Austria
Medizinische Universitat Graz ( Site 0303)
Graz, Austria
Medizinische Universitaet Innsbruck ( Site 0301)
Innsbruck, Austria
Uniklinikum Salzburg Landeskrankenhaus ( Site 0304)
Salzburg, Austria
Antwerp University Hospital ( Site 0407)
Edegem, Belgium
Cliniques Universitaires Saint-Luc ( Site 0402)
Brussels, Belgium
Grand Hopital de Charleroi ( Site 0404)
Charleroi, Belgium
UZ Gent ( Site 0406)
Ghent, Belgium
UZ Leuven ( Site 0401)
Leuven, Belgium
Hospital Araújo Jorge ( Site 0518)
Goiânia, Brazil
Liga Norte Riograndense Contra o Câncer ( Site 0513)
Natal, Brazil
Irmandade da Santa Casa de Misericordia de Porto Alegre ( Site 0514)
Porto Alegre, Brazil
Hospital São Lucas da PUCRS ( Site 0516)
Porto Alegre, Brazil
Fundação Pio XII - Hospital de Câncer de Barretos ( Site 0511)
Barretos, Brazil
Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto ( Site 0512)
São José do Rio Preto, Brazil
IBCC - Instituto Brasileiro de Controle do Câncer ( Site 0517)
São Paulo, Brazil
Instituto Nacional de Câncer - INCA ( Site 0515)
Rio de Janeiro, Brazil
Sunnybrook Research Institute ( Site 0605)
Toronto, Canada
Princess Margaret Cancer Centre ( Site 0601)
Toronto, Canada
Centre Hospitalier de l'Université de Montréal ( Site 0616)
Montreal, Canada
McGill University Health Centre ( Site 0602)
Montreal, Canada
Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0611)
Québec, Canada
CIUSSS de l Estrie Centre Hospitalier Universitaire de Sherbrooke ( Site 0604)
Sherbrooke, Canada
CIDO SpA-Oncology ( Site 0708)
Temuco, Chile
IC La Serena Research ( Site 0710)
La Serena, Chile
FALP ( Site 0701)
Santiago, Chile
Pontificia Universidad Catolica de Chile-CICUC ( Site 0706)
Santiago, Chile
Bradfordhill ( Site 0702)
Santiago, Chile
ONCOCENTRO APYS-ACEREY ( Site 0703)
Viña del Mar, Chile
Clinica Somer ( Site 0903)
Rionegro, Colombia
Centro Cancerológico del Caribe (CECAC) ( Site 0906)
Barranquilla, Colombia
Instituto Nacional De Cancerologia ( Site 0909)
Bogotá, Colombia
Oncomédica S.A.S ( Site 0905)
Montería, Colombia
Oncólogos del Occidente S.A.S. ( Site 0908)
Pereira, Colombia
Fakultní Nemocnice Brno ( Site 1003)
Brno, Czechia
Nemocnice AGEL Novy Jicin a.s. ( Site 1004)
Nový Jičín, Czechia
Fakultni nemocnice Ostrava ( Site 1005)
Ostrava, Czechia
Fakultni nemocnice Kralovske Vinohrady ( Site 1002)
Prague, Czechia
Vseobecna fakultni nemocnice v Praze-Gynekologicko-porodnicka klinika 1.LF a VFN ( Site 1001)
Prague, Czechia
CHU Strasbourg-Hautepierre ( Site 1207)
Strasbourg, France
Oncopole Claudius Regaud ( Site 1203)
Toulouse, France
Hopital Europeen Georges Pompidou ( Site 1210)
Paris, France
Alexandra General Hospital of Athens-ONCOLOGY DEPT. ( Site 1401)
Athens, Greece
Aretaieio Hospital Oncology Unit ( Site 1402)
Athens, Greece
ATTIKON GENERAL UNIVERSITY HOSPITAL ( Site 1403)
Chaïdári, Greece
Országos Onkológiai Intézet ( Site 1603)
Budapest, Hungary
Debreceni Egyetem Klinikai Kozpont ( Site 1601)
Debrecen, Hungary
Mater Misercordiae University Hospital ( Site 1804)
Dublin, Ireland
Hillel Yaffe Medical Center ( Site 1903)
Hadera, Israel
Rambam Health Care Campus ( Site 1907)
Haifa, Israel
Carmel Hospital ( Site 1901)
Haifa, Israel
Shaare Zedek Medical Center ( Site 1905)
Jerusalem, Israel
Rabin Medical Center ( Site 1904)
Petah Tikva, Israel
Sourasky Medical Center ( Site 1902)
Tel Aviv, Israel
IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" ( Site 2009)
Meldola, Italy
CRO-IRCCS ( Site 2014)
Aviano, Italy
Ospedale Humanitas San Pio X ( Site 2013)
Milan, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 2008)
Milan, Italy
ASST Spedali Civili ( Site 2001)
Brescia, Italy
Ospedale Cannizzaro ( Site 2010)
Catania, Italy
Istituto Europeo di Oncologia ( Site 2003)
Milan, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Ginecologia Oncologica ( Site 2012)
Roma, Italy
Azienda Ospedaliera Ordine Mauriziano di Torino ( Site 2006)
Torino, Italy
Aichi Cancer Center ( Site 2114)
Nagoya, Japan
Kurume University Hospital ( Site 2112)
Kurume, Japan
Gunma Prefectural Cancer Center ( Site 2109)
Ōta, Japan
National Hospital Organization Hokkaido Cancer Center ( Site 2108)
Sapporo, Japan
Hyogo Cancer Center ( Site 2118)
Akashi, Japan
Iwate Medical University Hospital ( Site 2116)
Shiwa-gun, Japan
Kanagawa Cancer Center ( Site 2121)
Yokohama, Japan
University of the Ryukyus Hospital ( Site 2117)
Ginowan, Japan
Saitama Medical University International Medical Center ( Site 2106)
Hidaka, Japan
Shizuoka Cancer Center ( Site 2104)
Sunto-gun,, Japan
Cancer Institute Hospital of JFCR ( Site 2119)
Koto, Japan
The Jikei University Hospital ( Site 2107)
Minato, Japan
National Hospital Organization Kyushu Cancer Center ( Site 2102)
Fukuoka, Japan
Niigata Cancer Center Hospital ( Site 2110)
Niigata, Japan
Okayama University Hospital ( Site 2101)
Okayama, Japan
Osaka Prefectural Hospital Organization Osaka International Cancer Institute ( Site 2111)
Osaka, Japan
CANCER TREAMTENT CLINIC AND CLINICAL TRIALS SA DE CV ( Site 2204)
Guadalajara, Mexico
Grupo Médico ASSET ( Site 2203)
Mexico City, Mexico
Higiea Oncologia ( Site 2205)
Mexico City, Mexico
Hospital Universitario "Dr. Jose Eleuterio Gonzalez" ( Site 2202)
Monterrey, Mexico
Scientia Investigacion Clinica S.C. ( Site 2201)
Chihuahua City, Mexico
Centro de Investigacion Clinica de Oaxaca ( Site 2207)
Oaxaca City, Mexico
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy w Warszawie ( Site 2605)
Warsaw, Poland
Narodowy Instytut Onkologii - Oddzial w Gliwicach-III Klinika Radioterapii i Chemioterapii ( Site 2604)
Gliwice, Poland
Mazowiecki Szpital Wojewódzki w Siedlcach ( Site 2601)
Siedlce, Poland
Swietokrzyskie Centrum Onkologii. ( Site 2602)
Kielce, Poland
Hopelands Cancer Centre ( Site 2816)
Hilton, South Africa
National Cancer Center ( Site 2905)
Goyang-si, South Korea
Seoul National University Hospital ( Site 2901)
Jongno-gu, South Korea
Severance Hospital Yonsei University Health System ( Site 2902)
Seodaemun-Gu, South Korea
Asan Medical Center ( Site 2904)
Seoul, South Korea
Samsung Medical Center ( Site 2903)
Seoul, South Korea
Institut Català d'Oncologia (ICO) - Girona ( Site 3002)
Girona, Spain
Hosp Clinico Universitario de Valencia ( Site 3001)
Valencia, Spain
Hospital Universitari Vall d Hebron ( Site 3003)
Barcelona, Spain
Hospital Universitario Reina Sofia ( Site 3006)
Córdoba, Spain
Hospital Ramon y Cajal ( Site 3005)
Madrid, Spain
Hospital Universitario 12 de Octubre ( Site 3007)
Madrid, Spain
Hospital Universitario La Paz ( Site 3004)
Madrid, Spain
Skanes Universitetssjukhus Lund ( Site 3103)
Lund, Sweden
Karolinska Universitetssjukhuset-Solna ( Site 3102)
Stockholm, Sweden
Linköping University Hospital ( Site 3101)
Linköping, Sweden
National Taiwan University Hospital ( Site 3301)
Taiwan, Taiwan
Taichung Veterans General Hospital ( Site 3304)
Taichung, Taiwan
National Cheng Kung University Hospital ( Site 3308)
Tainan, Taiwan
Mackay Memorial Hospital ( Site 3303)
Taipei, Taiwan
Chang Gung Memorial Hospital ( Site 3302)
Taoyuan, Taiwan
Chulalongkorn University ( Site 3403)
Bangkok, Thailand
Ramathibodi Hospital ( Site 3404)
Bangkok, Thailand
Faculty of Medicine Siriraj Hospital ( Site 3401)
Bangkok, Thailand
Maharaj Nakorn Chiang Mai Hospital ( Site 3402)
Chiang Mai, Thailand
The Christie Hospital NHS Foundation Trust ( Site 3602)
Withington, United Kingdom
Trial contact
Toll Free Number
Contact information from ClinicalTrials.gov. Contact in English.
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/3/2026.